Eledon Pharmaceuticals | S-3:特定交易注册声明
Eledon Pharmaceuticals | D:发行公告
Eledon Pharmaceuticals | 10-Q:季度报表
Eledon Pharmaceuticals | 4:持股变动声明-股东 BVF PARTNERS L P/IL
Eledon Pharmaceuticals | 8-K:Eledon Pharmicals公布2024年第一季度运营和财务业绩
Eledon Pharmaceuticals | 8-K:重大事件
Eledon Pharmaceuticals | 10-K/A:年度报表(修正版)
Eledon Pharmaceuticals | 10-K:年度报表
Eledon Pharmaceuticals | 8-K:Eledon Pharmicals公布2023年第四季度和全年运营和财务业绩
Eledon Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Eledon Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
Eledon Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(17.9%),BVF Inc.(17.9%)等
Eledon Pharmaceuticals:2023财年三季报
Eledon Pharmaceuticals | 8-K:Eledon Pharmicals公布2023年第三季度经营和财务业绩
Eledon Pharmaceuticals | 8-K:重大事件
Eledon Pharmaceuticals | 4:持股变动声明-董事 Robinson James A. Jr.
Eledon Pharmaceuticals | 4:持股变动声明-董事 Kirk Allan
Eledon Pharmaceuticals | 3:首次持股声明-董事 Robinson James A. Jr.
Eledon Pharmaceuticals | 3:首次持股声明-董事 Kirk Allan
Eledon Pharmaceuticals | 8-K:重大事件
暂无数据